Medicines for Ireland strategic review calls for agreement with Department of Health on supply and pricing of off-patent medicines
Medicines for Ireland
Average of 567 days from time drug authorised by European Medicines Agency to being made available to patients
Supply chain disruption and pricing issues are affecting supply just as winter infections surge in Ireland
Industry group for generics and biosimilars says drug costs a ‘millstone’ for HSE funding
Industry group says it has put proposals to the Government to avert any shortages
New stockpile will be available to Member States fighting impact of coronavirus
Spending on high-tech drugs almost doubles to over €660m in nine years
Government to save €15m this year as prices fall across 750 drugs
Pharmaceutical companies also warn of higher costs for HSE
Industry urges UK and EU to grasp importance of ongoing co-operation on drugs
Industry group calls for a radical overhaul of medicines policy in Ireland
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices